255 related articles for article (PubMed ID: 15153083)
1. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control.
Chen LC; Elliott RA; Ashcroft DM
J Clin Pharm Ther; 2004 Jun; 29(3):215-29. PubMed ID: 15153083
[TBL] [Abstract][Full Text] [Related]
2. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B
Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain.
Rømsing J; Møiniche S
Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847
[TBL] [Abstract][Full Text] [Related]
4. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Matheson AJ; Figgitt DP
Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model.
Korn S; Vassil TC; Kotey PN; Fricke JR
Clin Ther; 2004 May; 26(5):769-78. PubMed ID: 15220020
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
[TBL] [Abstract][Full Text] [Related]
8. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
Fenton C; Keating GM; Wagstaff AJ
Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329
[TBL] [Abstract][Full Text] [Related]
9. [Clinical pharmacology of the selective COX-2 inhibitors].
Burian M; Geisslinger G
Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
[TBL] [Abstract][Full Text] [Related]
10. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review.
McDaid C; Maund E; Rice S; Wright K; Jenkins B; Woolacott N
Health Technol Assess; 2010 Mar; 14(17):1-153, iii-iv. PubMed ID: 20346263
[TBL] [Abstract][Full Text] [Related]
11. The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials.
Morrison BW; Fricke J; Brown J; Yuan W; Kotey P; Mehlisch D
J Am Dent Assoc; 2000 Dec; 131(12):1729-37. PubMed ID: 11143737
[TBL] [Abstract][Full Text] [Related]
12. Selecting new drugs for pain control: evidence-based decisions or clinical impressions?
Jeske AH
J Am Dent Assoc; 2002 Aug; 133(8):1052-6; quiz 1093-4. PubMed ID: 12198983
[TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
14. Single dose oral rofecoxib for postoperative pain.
Barden J; Edwards J; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2005 Jan; (1):CD004604. PubMed ID: 15674955
[TBL] [Abstract][Full Text] [Related]
15. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
16. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
Stephens J; Laskin B; Pashos C; Peña B; Wong J
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
[TBL] [Abstract][Full Text] [Related]
17. Analgesic efficacy of rofecoxib compared with codeine/acetaminophen using a model of acute dental pain.
Chang DJ; Bird SR; Bohidar NR; King T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Oct; 100(4):e74-80. PubMed ID: 16182156
[TBL] [Abstract][Full Text] [Related]
18. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
Reuben SS; Connelly NR
Anesth Analg; 2000 Nov; 91(5):1221-5. PubMed ID: 11049912
[TBL] [Abstract][Full Text] [Related]
19. COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
Cicconetti A; Bartoli A; Ripari F; Ripari A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):139-46. PubMed ID: 14970772
[TBL] [Abstract][Full Text] [Related]
20. The COX-2 inhibitors: new analgesic and anti-inflammatory drugs.
Khan AA; Dionne RA
Dent Clin North Am; 2002 Oct; 46(4):679-90. PubMed ID: 12436824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
